BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
At close: May 6, 2026
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 3.09 million as of October 30, 2026. It is the 47,739th most valuable company in the world and the 2,141st biggest in Canada. Its market cap has decreased by 64.94% in one year.
Market Cap
3.09M
Enterprise Value
3.22M
Revenue
n/a
Global Rank
Country Rank
#2,141 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 3.09M, a decrease of -88.59%. That is a compound annual growth rate of -32.21%.
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 3.09M | -68.18% |
| Dec 31, 2025 | 9.70M | -41.13% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rakovina Therapeutics | 8.47M |
| Glow Lifetech | 7.70M |
| Kane Biotech | 7.18M |
| MYND Life Sciences | 5.22M |
| PharmaTher Holdings | 5.01M |
| Restart Life Sciences | 4.38M |
| Grey Matters Health | 4.01M |
| Innovotech | 3.54M |